[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![adamfeuerstein Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::102094857.png) Adam Feuerstein ✡️ [@adamfeuerstein](/creator/twitter/adamfeuerstein) on x 119.4K followers
Created: 2025-07-22 18:35:55 UTC

Sarepta Therapeutics, $SRPT the maker of a gene therapy for Duchenne muscular dystrophy that is being temporarily shelved because of safety concerns, faces an “arduous and treacherous path” to try to get it back onto the market, a senior official at the Food and Drug Administration told STAT, suggesting the treatment’s license could be revoked.


XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947727324528476319/c:line.svg)

**Related Topics**
[told](/topic/told)
[$srpt](/topic/$srpt)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/adamfeuerstein/status/1947727324528476319)